Palestine News

New drug cuts relapse risk by half in rare immune disorder trial

Written by

wpadmin

in

In IgG4-related disease, B cells (above) attack the body’s own tissue. A study led by Stanford Medicine has found that a drug reduces the chance of relapse. Credit: National…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts